Our Vision

Bringing light to the science of cognition research.

The mission of the LuMind Research Down Syndrome Foundation is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down Syndrome.

Our Approach  Learn More

How Your Donation Helps

Cognition research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective therapies to improve cognition and delay the onset of Alzheimer’s disease within the Ds community. Your gift is crucial to furthering these breakthroughs.

By the Numbers

Down syndrome in our community and the world.

US Statistics

250,000 - 400,000

The number persons with Down syndrome in the US

Worldwide Numbers


Estimated number of people with Down syndrome worldwide

Dollars per person


The amount of research dollars per diagnosed person with Down syndrome

LuMind RDS News

The LuMind 321 Virtual Run is On! What’s Your 321 Activity?

Join us and register your 321 activity to celebrate World Down Syndrome Day! In 2013, Siobhan Pritchard created the World Down Syndrome Day 321 Virtual Run for LuMind RDS for anyone, anywhere to “actively” support people with Down syndrome because she cared. LuMind™ Research Down Syndrome Foundation (LuMind RDS) CARES since we believe Cognition And Research Empowers Success.  …

Read More

Have you checked out the Down syndrome scene in Austin? It’s sizzling!

We have a lot in common with some friends in Austin who care a great deal about cognition research. They have hosted Research 101 events for their members and have consistently contributed funding for research since 2012 from their Buddy Walk — over $99,000 in 5 years! So we recently asked their executive director, Cameron …

Read More

LuMind RDS Board Welcomes Hector Guinness and Bjoern Sperling!

Last year, the LuMind RDS Board of Directors agreed that a new vision — to be a global leader in funding a comprehensive portfolio of research to meaningfully improve memory, cognition, and independence in individuals with Down syndrome — will guide the next decade of growth and innovation. That growth began at the top with the …

Read More

What people are saying about us.

“I never thought I would be in a position to say, ‘We are going to take therapies forward to directly treat Down syndrome.’ Now I think that is the case. We really are in the early stages of a revolution in understanding the basis for many of the features that occur in Down syndrome.”

Dr. Roger Reeves, Johns Hopkins